Alaunos Therapeutics, Inc. (TCRT)
1.50
-0.06
(-3.85%)
USD |
NASDAQ |
Sep 10, 16:00
1.50
0.00 (0.00%)
After-Hours: 20:00
Alaunos Therapeutics Shareholders Equity (Quarterly) : 0.652M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.652M |
| March 31, 2026 | 1.288M |
| December 31, 2025 | 2.153M |
| September 30, 2025 | 2.803M |
| June 30, 2025 | 3.661M |
| March 31, 2025 | 1.058M |
| December 31, 2024 | 2.063M |
| September 30, 2024 | 2.724M |
| June 30, 2024 | 3.771M |
| March 31, 2024 | 4.797M |
| December 31, 2023 | 6.307M |
| September 30, 2023 | 13.90M |
| June 30, 2023 | 21.65M |
| March 31, 2023 | 29.51M |
| December 31, 2022 | 38.56M |
| September 30, 2022 | 32.11M |
| June 30, 2022 | 40.18M |
| March 31, 2022 | 49.12M |
| December 31, 2021 | 58.06M |
| September 30, 2021 | 68.71M |
| June 30, 2021 | 88.28M |
| March 31, 2021 | 105.64M |
| December 31, 2020 | 123.98M |
| September 30, 2020 | 144.92M |
| June 30, 2020 | 163.41M |
| Date | Value |
|---|---|
| March 31, 2020 | 180.34M |
| December 31, 2019 | 95.01M |
| September 30, 2019 | 106.13M |
| June 30, 2019 | 62.00M |
| March 31, 2019 | 74.22M |
| December 31, 2018 | 85.56M |
| September 30, 2018 | 4.015M |
| June 30, 2018 | 15.19M |
| March 31, 2018 | 25.89M |
| December 31, 2017 | 47.19M |
| September 30, 2017 | 59.27M |
| June 30, 2017 | 69.96M |
| March 31, 2017 | 34.54M |
| December 31, 2016 | 48.02M |
| September 30, 2016 | 57.40M |
| June 30, 2016 | -51.99M |
| March 31, 2016 | 77.81M |
| December 31, 2015 | 87.37M |
| September 30, 2015 | 93.84M |
| June 30, 2015 | 110.44M |
| March 31, 2015 | 120.60M |
| December 31, 2014 | 33.84M |
| September 30, 2014 | 36.48M |
| June 30, 2014 | 37.72M |
| March 31, 2014 | 41.73M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 11.69B |
| Anika Therapeutics, Inc. | 137.28M |
| BioCryst Pharmaceuticals, Inc. | -454.29M |
| Imunon, Inc. | 4.189M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.516M |
| Total Liabilities (Quarterly) | 0.864M |
| Current Ratio | 0.7708 |